Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
10/2013
10/30/2013EP2657236A1 Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
10/30/2013EP2655374A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
10/30/2013EP2655373A1 Preparation process of an antiviral drug (entecavir) and intermediates thereof
10/30/2013CN103373999A Purine compound, intermediate, preparation method and application thereof
10/30/2013CN103373971A Urea compounds serving as protein kinase inhibitors
10/29/2013US8569491 Method for preparing entecavir and intermediate used therein
10/29/2013US8569490 Intermediate and process for preparing entecavir using same
10/29/2013US8569489 7-[4-(Benzhydrylpiperazinyl-1)butyl]-3-methylxanthine and its salts with organic or inorganic acids possessing antihistaminic and antiallergenic activity
10/29/2013US8569478 Modified 4′-nucleosides as antiviral agents
10/29/2013CA2607021C Diaryl-purines, -azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
10/24/2013WO2013159006A1 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione
10/24/2013WO2013157562A1 Nitrogenated bicyclic aromatic heterocyclic compound
10/24/2013WO2013157021A1 Bicyclic compounds, compositions and medicinal applications thereof
10/24/2013WO2012159072A4 Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins
10/24/2013US20130281685 iRNA AGENTS WITH BIOCLEAVABLE TETHERS
10/24/2013US20130281517 Cyclopropanecarboxylate esters of purine analogues
10/24/2013US20130281470 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases
10/23/2013EP2651943A1 Purine derivatives
10/23/2013CN103360394A 8-chlorotheophylline preparation method
10/23/2013CN103360393A Preparation method of theophylline-7-acetic acid
10/22/2013US8563717 Adenine derivatives
10/17/2013US20130274273 Inhibiting Transient Receptor Potential Ion Channel TRPA1
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351389A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/16/2013CN103351388A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
10/16/2013CN101240001B 2'-fluoro nucleotide
10/15/2013US8557830 RAF kinase modulators and methods of use
10/10/2013WO2013150416A1 Diacylglycerol acyltransferase 2 inhibitors
10/10/2013US20130267526 Heterocyclic compounds and their uses
10/09/2013EP2647637A2 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
10/09/2013EP2646455A2 Modulators of histone methyltransferase, and methods of use thereof
10/09/2013EP2646441A2 Carbocycle-substituted purine and 7-deazapurine compounds
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/08/2013US8552011 6-(C2-6alkylseleno)purines and methods for treating neural measles viral infection therewith
10/08/2013CA2542898C Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
10/03/2013WO2013143927A1 Co-crystals of dicamba and a co-crystal former b
10/02/2013EP2644195A1 Immunosuppressant Compounds and Compositions
10/02/2013EP2642987A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
10/02/2013CN103339132A Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredi
09/2013
09/26/2013US20130252976 Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
09/25/2013CN103329299A Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
09/25/2013CN103319485A 6-(beta-alkylnaphthy)mercaptopurine compound, and synthesis method and application thereof
09/25/2013CN103319484A Synthetic method for 6-purinethol
09/25/2013CN103319483A Preparation method of important intermediate of linagliptin
09/25/2013CN101679434B 2, 6, 9-substituted purine derivatives having anti proliferative properties
09/25/2013CN101293888B Xanthine derivative, production and use thereof as a medicament
09/24/2013CA2466697C Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
09/19/2013WO2013135165A1 Synthetic intermediate of entecavir and method for preparing same
09/19/2013US20130245046 Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
09/18/2013EP2637669A2 Heterocyclic compounds and uses thereof
09/18/2013CN103313707A Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
09/18/2013CN103304566A Novel crystalline entecavir
09/18/2013CN103304490A Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark
09/18/2013CN103304375A Synthesis intermediate of Entecavir and preparation method thereof
09/17/2013CA2740471C Morpholinopurine derivatives
09/17/2013CA2669503C Compounds and methods for thiol-containing compound efflux and cancer treatment
09/12/2013WO2013134288A1 Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
09/12/2013WO2013134079A1 Oxazolidinone compounds and derivatives thereof
09/11/2013EP2635565A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors
09/11/2013CN103298812A Process for the preparation of tenofovir
09/11/2013CN101928288B Small molecule compositions for binding to HSP90
09/10/2013US8531480 Data-driven layout engine
09/10/2013CA2608490C Preparation of famciclovir and other purine derivatives
09/10/2013CA2577588C Hiv inhibiting bicyclic pyrimidine derivatives
09/06/2013WO2013130890A1 Heterobicyclic compounds and their use as phosphodiesterase inhibitors
09/05/2013US20130231480 Sequence specific double-stranded dna/rna binding compounds and uses thereof
09/05/2013US20130231356 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
09/05/2013US20130231337 Bicyclic Heteroaryl Compounds
09/04/2013CN103275079A Preparation method for 8-aryl or vinyl-substituted xanthine compound
09/04/2013CN101646669B Purinyl derivatives and their use as potassium channel modulators
09/03/2013US8524899 Alternative heterocycles for DNA recognition
09/03/2013US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
09/03/2013CA2595182C Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
08/2013
08/29/2013US20130225564 Haloaryl substituted aminopurines, compositions thereof,and methods of treatment therewith
08/29/2013US20130225552 Heterobicyclic compounds
08/28/2013CN103270038A Preparation process of an antiviral drug (entecavir) and intermediates thereof
08/28/2013CN103265543A Inhibiting transient receptor potential ion channel TRPA1
08/28/2013CN103265542A Purine derivative and preparation method thereof
08/27/2013US8518957 Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure
08/22/2013WO2013123335A1 Peripherally restricted diphenyl purine derivatives
08/22/2013US20130217880 Purinone derivative
08/22/2013US20130217879 Entecavir synthesis method and intermediate compound thereof
08/21/2013EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
08/21/2013CN103261890A Inhibitors of human ezh2, and methods of use thereof
08/21/2013CN103261200A Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications
08/21/2013CN103254194A Preparation method of 8-thiaxanthine compound
08/21/2013CN103254193A 黄嘌呤类化合物中间体及其制备方法 Xanthine compound intermediates and preparation method
08/21/2013CN103254192A Xanthine compound, its salt, intermediates, preparation method and application
08/21/2013CN102216302B Akt and p70 s6 kinase inhibitors
08/21/2013CN101899010B Quinazol derivative, preparation method and application thereof
08/20/2013CA2559036C 9-substituted 8-oxoadenine compound
08/15/2013US20130210826 Methods for treating pain
08/14/2013CN103242314A Method for comprehensively extracting effective ingredients in tea
08/14/2013CN103242313A Method for recovering sodium theophylline mother liquid
08/14/2013CN103242243A Base acetic acid glycerin ester ether molecule, chemical synthesis method of molecule, and application of molecule in field of gene therapy
08/13/2013US8507661 Modified iRNA agents
08/13/2013US8507507 Modulators of toll-like receptors
08/13/2013CA2743019C Akt and p70 s6 kinase inhibitors
08/13/2013CA2554782C Methods to manufacture 1,3-dioxolane nucleosides
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 120